Zurich Cantonal Bank
MRNA icon

Zurich Cantonal Bank’s Moderna MRNA Stock Holding History

Zurich Cantonal Bank’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.4M Buy
162,175
+2,014
+1% +$104K 0.02% 461
2026
Q1 		$8.14M Buy
+160,161
New +$7.47M 0.02% 539
2025
Q4 		– Sell
-117,169
Closed -$3.18M – 3139
2025
Q3 		$3.03M Buy
117,169
+10,715
+10% +$299K 0.01% 749
2025
Q2 		$2.94M Sell
106,454
-85,852
-45% -$2.26M 0.01% 724
2025
Q1 		$5.45M Sell
192,306
-134,443
-41% -$4.77M 0.02% 567
2024
Q4 		$13.6M Buy
326,749
+168,975
+107% +$8.08M 0.04% 368
2024
Q3 		$10.5M Buy
157,774
+23,631
+18% +$2.17M 0.03% 428
2024
Q2 		$15.9M Buy
134,143
+896
+0.7% +$113K 0.05% 309
2024
Q1 		$14.2M Buy
133,247
+15,611
+13% +$1.57M 0.05% 325
2023
Q4 		$11.7M Buy
117,636
+50,504
+75% +$4.25M 0.04% 345
2023
Q3 		$6.93M Sell
67,132
-206
-0.3% -$23K 0.03% 425
2023
Q2 		$8.18M Buy
67,338
+2,956
+5% +$394K 0.04% 397
2023
Q1 		$9.89M Sell
64,382
-43,756
-40% -$7.22M 0.05% 342
2022
Q4 		$19.4M Sell
108,138
-8,516
-7% -$1.39M 0.1% 185
2022
Q3 		$13.8M Sell
116,654
-739
-0.6% -$112K 0.08% 228
2022
Q2 		$16.8M Sell
117,393
-19,891
-14% -$2.84M 0.1% 199
2022
Q1 		$23.6M Buy
137,284
+31,298
+30% +$5.27M 0.12% 165
2021
Q4 		$26.9M Buy
105,986
+26,391
+33% +$7.72M 0.13% 143
2021
Q3 		$30.6M Buy
79,595
+171
+0.2% +$63.1K 0.17% 114
2021
Q2 		$18.7M Buy
79,424
+20,923
+36% +$3.74M 0.1% 194
2021
Q1 		$7.66M Buy
58,501
+2,040
+4% +$296K 0.05% 378
2020
Q4 		$5.9M Sell
56,461
-17,445
-24% -$1.76M 0.04% 439
2020
Q3 		$5.23M Buy
73,906
+15,827
+27% +$1.1M 0.04% 419
2020
Q2 		$3.73M Buy
+58,079
New +$3.18M 0.03% 458

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Zurich Cantonal Bank's MRNA Position: Q2 2026 in Review

Zurich Cantonal Bank increased its Moderna (MRNA) stake by 1.3% in Q2 2026, buying an estimated $104K and bringing the position to 162,175 shares worth $11.4M. The position accounts for 0.02% of the portfolio, ranked #461.

Zurich Cantonal Bank first reported a position in MRNA in Q2 2020 and has held it in 24 quarters since. The position peaked at $30.6M in Q3 2021. 780 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Zurich Cantonal Bank held 162,175 shares of Moderna worth $11.4M as of Q2 2026.
  • Zurich Cantonal Bank bought 2,014 Moderna shares in Q2 2026, an estimated $104K.
  • Moderna made up 0.02% of Zurich Cantonal Bank's portfolio in Q2 2026, its #461 holding.
  • Zurich Cantonal Bank first reported a position in Moderna in Q2 2020 and has held it in 24 quarters since.
  • Zurich Cantonal Bank's Moderna position peaked at $30.6M in Q3 2021.
  • 780 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.